Press release content from PR Newswire. The AP news staff was not involved in its creation.
Stand Up To Cancer Announces $4 Million Grant From Mirati Therapeutics To Support Research On KRAS Mutant Cancers
April 19, 2021 GMT
LOS ANGELES and SAN DIEGO, April 19, 2021 /PRNewswire/ Stand Up To Cancer® (SU2C) and Mirati Therapeutics Inc. (NASDAQ: MRTX) – a late-stage targeted oncology company – today announced that Mirati will contribute a $4 million grant to SU2C to develop new approaches to treat patients with KRAS mutant cancers, as a part of the SU2C Catalyst® program.
The research will focus on cancer types with unmet medical needs, and the application of tumor-agnostic strategies and molecular testing to address those needs. Certain cancers can sometimes have mutations in the KRAS gene, which makes a protein involved in cellular growth and death. In KRAS mutant cancers, that protein can cause cancers to grow and spread. KRAS proteins were once considered undruggable, bu
Jamie Foxx, Stand Up To Cancer And Exact Sciences Launch PSA To Increase Awareness Of Colorectal Cancer
USA - English
News provided by
Share this article
LOS ANGELES, March 17, 2021 /PRNewswire-HISPANIC PR WIRE/ Academy Award® winner
Jamie Foxx has joined Stand Up To Cancer® (SU2C) and Exact Sciences for a new public service announcement (PSA), which raises awareness about colorectal cancer screenings, early detection and prevention, and focuses on reaching underrepresented communities. The campaign launched today to coincide with Colorectal Cancer Awareness Month and is in both English and Spanish. The PSA will be placed across print, broadcast, radio, digital and out-of-home outlets.
Wülfershäuser bewegen sich mehr als der Durchschnitt mainpost.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mainpost.de Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK, Jan. 21, 2021 /PRNewswire/ Stand Up To Cancer® (SU2C) today announced $3.25 million in grants from four national nonprofits to fund research to find new treatments for head and neck cancers, which are newly diagnosed in about 65,000 Americans every year.
The grants include contributions of $1.5 million each from the Fanconi Anemia Research Fund and the Farrah Fawcett Foundation. The American Head and Neck Society and the Head and Neck Cancer Alliance are each providing $125,000 to support the project.
The grants will support new approaches to treating head and neck cancers, especially those associated with Fanconi anemia and human papillomavirus, or HPV. Fanconi anemia is a rare inherited disease that often leads to bone marrow failure and cancer; the incidence of head and neck squamous cell carcinoma in people with Fanconi anemia is 500- to 700-fold higher than in the general population and treatment options are limited. HPV is
E-Mail
IMAGE: Stand Up To Cancer® has received $3.25 million in grants from four national nonprofits to fund research to find new treatments for head and neck cancers, which are newly diagnosed. view more
Credit: Stand Up To Cancer
(New York) January 21 2021 - Stand Up To Cancer® (SU2C) today announced $3.25 million in grants from four national nonprofits to fund research to find new treatments for head and neck cancers, which are newly diagnosed in about 65,000 Americans every year.
The grants include contributions of $1.5 million each from the Fanconi Anemia Research Fund and the Farrah Fawcett Foundation. The American Head and Neck Society and the Head and Neck Cancer Alliance are each providing $125,000 to support the project.